SHBG and Insulin resistance: Decreased lipocalin levels and increased inflammatory factors such as tumor necrosis factor and interleukin 1β can inhibit SHBG production (31, 32) and SHBG may be an early marker of insulin resistance and disorders of glucose and lipid metabolism.